ADHD Drugs Market to Hit $22.79B by 2035 as Adult Diagnosis Grows
Image
London – October 16, 2026 -- The global ADHD drugs market will grow from USD 14.11 billion in 2025 to USD 22.79 billion by 2035, a compound annual growth rate of 4.91%, according to Credence Research Inc. The figures are the research firm's proprietary estimates, not audited sales totals.
North America holds 60% of value while Asia Pacific grows fastest at 6.34%
North America accounted for 60.0% of 2025 market value. Europe followed with 20.0%, Asia Pacific with 13.0%, Latin America with 4.0% and the Middle East and Africa with 3.0%.
Credence attributes Asia Pacific's 6.34% annual growth to better recognition and access in Japan, Australia and, increasingly, China, from a comparatively small revenue base. In Europe, reimbursement systems and lower net medicine prices restrain value per patient.